Close Menu

NEW YORK (360Dx) – Chembio Diagnostics said today it has received US Food and Drug Administration emergency use authorization (EUA) for its DPP Zika System.

The authorization makes the test available for use in high- and moderate-complexity CLIA-certified laboratories.

Under the EUA, the diagnostic can be used to test subjects meeting Centers for Disease Control and Prevention Zika virus clinical and/or epidemiological criteria. The system uses the company's DPP Micro Reader to detect Zika virus IgM antibodies in fingerstick whole blood.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.